Ibrutinib selectively and irreversibly targets EGFR (L858R, Del19) mutant but is moderately resistant to EGFR (T790M) mutant NSCLC Cells
Hong Wu(Chinese Academy of Sciences), Qingsong Liu(University of Science and Technology of China)
Cited by 46
Related Papers
Multidimensional Internet Use, Social Participation, and Depression Among Middle-Aged and Elderly Chinese Individuals: Nationwide Cross-Sectional Study
|Journal of Medical Internet Research|2023|88
Ibrutinib targets mutant-EGFR kinase with a distinct binding conformation
|Oncotarget|2016|47
Osimertinib successfully combats EGFR-negative glioblastoma cells by inhibiting the MAPK pathway
|Acta Pharmacologica Sinica|2020|33
Hydroxychloroquine facilitates autophagosome formation but not degradation to suppress the proliferation of cervical cancer SiHa cells
|Oncology Letters|2014|30
LncRNA uc.48+ is involved in the diabetic immune and inflammatory responses mediated by P2X7 receptor in RAW264.7 macrophages
|International Journal of Molecular Medicine|2018|25